TeÑajura, William Jay B.

HRN: 29-23-52  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/30/2026
07/07/2026
IV
500mg
Q8HRS
RUPTURED APPENDIX
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: